# Paclitaxel (TLX) and cetuximab (CTX) combination efficiency after failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma (RMHNSCC).

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/paclitaxel-tlx-and-cetuximab-ctx-combination-efficiency-after-failure-of-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | P. Céruse,Emilie Lavergne,Guillaume Buiret,Binh V. Pham,Sylvie Chabaud,Bertrand Favier,D. Girodet,Philippe Zrounba,Jérôme Fayette |
| Citations | 7 |
| DOI | 10.1200/jco.2011.29.15_suppl.5549 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2591348819 |
| Type | conference-abstract |
| Year | 2011 |

## Paper authors

- [Binh V. Pham](https://scholariq.org/researchers/binh-v-pham/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

## Paper topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.